Kamiren (Doxazosin)

Doxazosin works by selectively blocking alpha‑1 adrenergic receptors on blood vessels and in the prostate. This blockade prevents norepinephrine‑mediated constriction, leading to vasodilation and reduced peripheral resistance, while also relaxing smooth muscle in the lower urinary tract.

The exact dose of Kamiren is determined by the prescribing clinician based on the patient’s condition, age, renal function and response to therapy. Typical starting doses are low and are gradually increased until the desired blood‑pressure or urinary‑symptom control is achieved.

Safety data for doxazosin in pregnancy and lactation are limited. It should only be used if the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare professional.

To order Kamiren, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

For hypertension, doxazosin belongs to the alpha‑blocker class, offering an alternative to ACE inhibitors, ARBs or calcium‑channel blockers, especially when patients need additional vasodilation. In BPH, it is comparable to other alpha‑1 blockers such as terazosin and tamsulosin, with a similar efficacy profile but differing side‑effect patterns.

Kamiren should be stored at ambient temperature, preferably below 25 °C, in its original packaging to protect it from moisture and direct sunlight. Keep the product out of reach of children and do not use it after the expiration date printed on the label.

Kamiren is taken orally, usually once daily. It can be swallowed with or without food, but patients should follow the specific instructions given by their prescriber and avoid crushing or chewing the tablet unless directed otherwise.

The most serious risks include severe hypotension or syncope, especially after the first dose, priapism, and rare but potentially life‑threatening allergic reactions such as angioedema. Patients should seek immediate medical attention if they experience sudden dizziness, fainting, prolonged erection, or swelling of the face and throat.

Kamiren is contraindicated in patients with known hypersensitivity to doxazosin or any component of the formulation, and in those with severe hypotension. Caution is also advised for individuals taking certain medications that can cause additive blood‑pressure lowering effects, and for patients with uncontrolled heart failure.